Enno Spillner
CEO
Nanotechnology
Nanobiotix
Greece
Biography
Enno Spillner has more than 14 years’ experience in the life science industry and is now CEO and CFO of the listed German biotech company, 4SC AG, which is developing innovative targeted drugs for the treatment of cancer and autoimmune diseases.
Research Interest
Enno Spillner has extensive experience in finance, capital market transactions and in strategic corporate development. Prior to 4SC, he was Head of Finance and Managing Partner of the German regional biotech venture fund, BioM AG. He was also Managing Director of two portfolio companies, ACTIPAC Biosystems GmbH and Munich innovative Biomaterials GmbH.
